Canadian researchers discover genetic clue to peanut allergy
Food in CanadaFood In Canada Food Safety Food Trends Research & Development Bake & Snack Food Beverages Confectionery Specialty Foods food allergies
The Allergy, Genes and Environment Network says the researchers' work shows evidence that genes play a role in food allergies
Hamilton, Ont. – Canadian researchers, says the Allergy, Genes and Environment Network (AllerGen), have pinpointed a new gene associated with peanut allergy.
In a press release (“New genetic clue to peanut allergy,” on Oct. 10, 2017), AllerGen says the discovery offers “further evidence that genes play a role in the development of food allergies and opening the door to future research, improved diagnostics and new treatment options.”
AllerGen is a national research network funded by Innovation, Science and Economic Development Canada through the Network of Centres of Excellence program.
In the statement, AllerGen explains that “the gene, called c11orf30/EMSY (EMSY), is already known to play a role in other allergy-related conditions, such as eczema, asthma, and allergic rhinitis. This study is the first to associate the EMSY locus with food allergy, and these findings suggest that the gene plays an important role in the development of not just food allergy but also general allergic predisposition.”
The AllerGen researchers included Dr. Denise Daley, an associate professor at the University of B.C., Centre for Heart Lung Innovation at St. Paul’s Hospital in Vancouver; and Dr. Ann Clarke, a professor at the University of Calgary, Cumming School of Medicine in Calgary, and adjunct professor at McGill University in Montreal.
In the statement, Daley says that “the discovery of this genetic link gives us a fuller picture of the causes of food allergies and this could eventually help doctors identify children at risk.”
AllerGen says that an allergy to peanuts develops early in life “and is rarely outgrown.” Roughly one per cent of Canadian adults and between two and three per cent of Canadian children are affected. Symptoms can be severe to life-threatening.
The co-first authors of the study included Dr. Yuka Asai, an AllerGen investigator and assistant professor at Queen’s University, and AllerGen trainee Dr. Aida Eslami, a postdoctoral fellow at the University of B.C.
In the statement, Eslami says the results of the study “suggest that EMSY could be a useful target for predicting and managing food allergy treatments in the future.”
Print this page